![Lawrence David Mayer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lawrence David Mayer
Plus aucun poste en cours
Profil
Lawrence David Mayer is the founder of Celator Pharmaceuticals, Inc. which was founded in 1999.
He held the title of President & Chief Scientific Officer from 2013 to 2016.
Dr. Mayer also held former positions as a Principal at QLT, Inc. and The Canadian Liposome Co. Ltd. Dr. Mayer received a doctorate degree from the University of Minnesota in 1983 and an undergraduate degree from Wartburg College in 1978.
Anciens postes connus de Lawrence David Mayer
| Sociétés | Poste | Fin |
|---|---|---|
| CELATOR PHARMACEUTICALS INC | Fondateur | 12/07/2016 |
The Canadian Liposome Co. Ltd. | Corporate Officer/Principal | - |
QLT, Inc.
 QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Corporate Officer/Principal | - |
Formation de Lawrence David Mayer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
81
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets ocular products | Commercial Services |
Celator Pharmaceuticals, Inc.
 Celator Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat acute myeloid leukemia and AML with myelodysplasia in children & adults | Health Technology |
University of Minnesota
 University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wartburg College
 Wartburg College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Canadian Liposome Co. Ltd. |
